Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Burris

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
New anticancer agentsT D Brown, H A Burris, J R Eckardt, et al.
Archives of Dermatology|February 1, 1995
Acute cutaneous reactions to docetaxel, a new chemotherapeutic agentG C Zimmerman, J H Keeling, H A Burris, et al.
Gynecologic Oncology|November 28, 2006
A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignanciesM V Seiden, H A Burris, U Matulonis, et al.
Journal of the National Cancer Institute|January 5, 1994
Activity of intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitroJ R Eckardt, H A Burris, J G Kuhn, et al.
Journal of the National Cancer Institute|December 2, 1992
Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitroH A Burris, A R Hanauske, R K Johnson, et al.
Blood|May 16, 2000
Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphomaJ D Hainsworth, H A Burris, L H Morrissey, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 29, 1998
Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot studyH A Burris, C L Vogel, D Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancerP M Ravdin, H A Burris, G Cook, et al.
Investigational New Drugs|April 6, 2006
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxaneJ A Ajani, H Safran, C Bokemeyer, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
New anticancer agentsG R Weiss, H A Burris, J R Eckardt, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
New anticancer agentsT D Brown, H A Burris, J R Eckardt, et al.
Archives of Dermatology|February 1, 1995
Acute cutaneous reactions to docetaxel, a new chemotherapeutic agentG C Zimmerman, J H Keeling, H A Burris, et al.
Gynecologic Oncology|November 28, 2006
A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignanciesM V Seiden, H A Burris, U Matulonis, et al.
Journal of the National Cancer Institute|January 5, 1994
Activity of intoplicine (RP60475), a new DNA topoisomerase I and II inhibitor, against human tumor colony-forming units in vitroJ R Eckardt, H A Burris, J G Kuhn, et al.
Journal of the National Cancer Institute|December 2, 1992
Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitroH A Burris, A R Hanauske, R K Johnson, et al.
Blood|May 16, 2000
Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphomaJ D Hainsworth, H A Burris, L H Morrissey, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 29, 1998
Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot studyH A Burris, C L Vogel, D Castro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancerP M Ravdin, H A Burris, G Cook, et al.
Investigational New Drugs|April 6, 2006
A multi-center phase II study of BMS-247550 (Ixabepilone) by two schedules in patients with metastatic gastric adenocarcinoma previously treated with a taxaneJ A Ajani, H Safran, C Bokemeyer, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
New anticancer agentsG R Weiss, H A Burris, J R Eckardt, et al.
Pageof 12